CA2796505C - Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis - Google Patents

Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis Download PDF

Info

Publication number
CA2796505C
CA2796505C CA2796505A CA2796505A CA2796505C CA 2796505 C CA2796505 C CA 2796505C CA 2796505 A CA2796505 A CA 2796505A CA 2796505 A CA2796505 A CA 2796505A CA 2796505 C CA2796505 C CA 2796505C
Authority
CA
Canada
Prior art keywords
therapy
patient
solute
blood
parameter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2796505A
Other languages
English (en)
French (fr)
Other versions
CA2796505A1 (en
Inventor
Alp Akonur
John Kenneth Leypoldt
Ying-Cheng Lo
Baris Ugur Agar
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of CA2796505A1 publication Critical patent/CA2796505A1/en
Application granted granted Critical
Publication of CA2796505C publication Critical patent/CA2796505C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1613—Profiling or modelling of patient or predicted treatment evolution or outcome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A61M1/1619—Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0496—Urine
    • A61M2202/0498—Urea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/15—Detection of leaks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Arrangement Of Elements, Cooling, Sealing, Or The Like Of Lighting Devices (AREA)
CA2796505A 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis Expired - Fee Related CA2796505C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32511310P 2010-04-16 2010-04-16
US61/325,113 2010-04-16
PCT/US2011/032736 WO2011130669A1 (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Publications (2)

Publication Number Publication Date
CA2796505A1 CA2796505A1 (en) 2011-10-20
CA2796505C true CA2796505C (en) 2018-12-11

Family

ID=44041518

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2796505A Expired - Fee Related CA2796505C (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
CA2796496A Expired - Fee Related CA2796496C (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2796496A Expired - Fee Related CA2796496C (en) 2010-04-16 2011-04-15 Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Country Status (10)

Country Link
EP (3) EP2558966B1 (enExample)
JP (8) JP5747072B2 (enExample)
AU (2) AU2011239488B2 (enExample)
BR (1) BR112012026361A2 (enExample)
CA (2) CA2796505C (enExample)
CO (3) CO6660434A2 (enExample)
ES (2) ES2802609T3 (enExample)
MX (5) MX347513B (enExample)
NZ (2) NZ603010A (enExample)
WO (2) WO2011130668A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132219B2 (en) 2010-04-16 2015-09-15 Baxter International Inc. Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
US8845570B2 (en) 2010-04-16 2014-09-30 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
MX361881B (es) * 2013-08-16 2018-12-18 Baxter Int Prediccion y optimizacion de terapia de potasio en suero para terapia de sangre para insuficiencia renal, especialmente hemodialisis domiciliaria.
DE102014005122B4 (de) * 2014-04-08 2026-06-25 Fresenius Medical Care Deutschland Gmbh Verfahren zur Abschätzung der Behandlungsdauer einer Pertionealdialyse-Behandlung
EP3539586B1 (en) 2014-10-10 2022-08-24 NxStage Medical Inc. Flow balancing methods
JP7086926B2 (ja) 2016-07-18 2022-06-20 ネクステージ メディカル インコーポレイテッド フローバランシングの装置、方法、及びシステム
EP3506962B1 (en) 2016-08-30 2023-11-22 NxStage Medical, Inc. Parameter monitoring in medical treatment systems
JP2019212249A (ja) * 2018-06-10 2019-12-12 大 益満 プログラム及び情報処理システム
CA3132978A1 (en) 2019-03-11 2020-09-17 Fresenius Medical Care Holdings, Inc. Techniques for determining acid-base homeostasis
AU2020277500B2 (en) 2019-05-23 2025-04-24 Nxstage Medical, Inc. Flow synchronization devices, methods and systems
CN115050238B (zh) * 2022-07-08 2024-03-12 卡斯柯信号有限公司 一种基于真实ctc系统的多模式切换仿真实训系统
JP2024113409A (ja) 2023-02-09 2024-08-22 フィジオロガス・テクノロジーズ株式会社 診療支援システム
EP4678200A4 (en) 2023-05-25 2026-07-08 Physiologas Tech Inc HEMODIALYSIS TREATMENT SUPPORT SYSTEM

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5230702A (en) * 1991-01-16 1993-07-27 Paradigm Biotechnologies Partnership Hemodialysis method
EP0616689B1 (en) * 1992-10-13 1999-04-14 Baxter International Inc. Fluid sampling module
JP2812460B2 (ja) * 1995-10-04 1998-10-22 日機装株式会社 血液浄化モニタ装置
JP3402360B2 (ja) * 1998-08-21 2003-05-06 株式会社ジェイ・エム・エス 腹膜透析システム
AUPP790898A0 (en) * 1998-12-23 1999-01-28 Life Therapeutics Limited Renal dialysis
ATE298595T1 (de) * 2002-09-05 2005-07-15 Gambro Lundia Ab Steuerung für eine blutbehandlungsvorrichtung
US20040048837A1 (en) * 2002-09-06 2004-03-11 Lazarus J. Michael Method for treatment of renal disease
JP4379027B2 (ja) * 2003-05-14 2009-12-09 株式会社ジェイ・エム・エス 腹膜透析および血液透析併用プランニング方法ならびに腹膜透析および血液透析併用プランニング装置
EP1902397B1 (en) * 2005-06-09 2010-04-14 Gambro Lundia AB Medical apparatus and method for setting up a medical apparatus
DE102006045437A1 (de) * 2006-09-26 2008-04-03 Fresenius Medical Care Deutschland Gmbh Vorrichtung und Verfahren zur Vorgabe einer Dialysierflüssigkeitsrate oder Blutflussrate für eine extrakorporale Blutbehandlung
US8393690B2 (en) 2007-02-27 2013-03-12 Deka Products Limited Partnership Enclosure for a portable hemodialysis system
US20090107335A1 (en) 2007-02-27 2009-04-30 Deka Products Limited Partnership Air trap for a medical infusion device
US8888470B2 (en) 2007-02-27 2014-11-18 Deka Products Limited Partnership Pumping cassette
US8562834B2 (en) 2007-02-27 2013-10-22 Deka Products Limited Partnership Modular assembly for a portable hemodialysis system
US8042563B2 (en) 2007-02-27 2011-10-25 Deka Products Limited Partnership Cassette system integrated apparatus
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
US8409441B2 (en) * 2007-02-27 2013-04-02 Deka Products Limited Partnership Blood treatment systems and methods
WO2009019535A1 (en) * 2007-08-03 2009-02-12 Koninklijke Philips Electronics N.V. A method, apparatus, computer-readable medium and use for pharmacokinetic modeling
US8062513B2 (en) 2008-07-09 2011-11-22 Baxter International Inc. Dialysis system and machine having therapy prescription recall
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US7981281B2 (en) 2008-07-09 2011-07-19 Baxter International, Inc. Dialysis system having regimen generation methodology
US8168063B2 (en) * 2008-07-09 2012-05-01 Baxter International Inc. Dialysis system having filtering method for determining therapy prescriptions
US8057679B2 (en) 2008-07-09 2011-11-15 Baxter International Inc. Dialysis system having trending and alert generation
EP2163272B1 (en) * 2008-09-15 2014-06-25 B. Braun Avitum AG Device to early predict the Kt/V parameter in kidney substitution treatments
WO2010045558A1 (en) * 2008-10-17 2010-04-22 Fresenius Medical Care Holdings, Inc. Method of determining a phosphorus binder dosage for a dialysis patient

Also Published As

Publication number Publication date
CO6620023A2 (es) 2013-02-15
JP7057321B2 (ja) 2022-04-19
NZ603010A (en) 2014-05-30
JP2024045513A (ja) 2024-04-02
JP6078582B2 (ja) 2017-02-08
JP6018567B2 (ja) 2016-11-02
JP7438257B2 (ja) 2024-02-26
EP2558966A1 (en) 2013-02-20
ES2501715T3 (es) 2014-10-02
CA2796496C (en) 2018-03-20
AU2011239488A1 (en) 2012-11-08
JP6043850B2 (ja) 2016-12-14
JP2013524892A (ja) 2013-06-20
BR112012026361A2 (pt) 2019-09-24
JP2015165914A (ja) 2015-09-24
AU2011239488B2 (en) 2015-05-21
ES2802609T3 (es) 2021-01-20
JP2013524893A (ja) 2013-06-20
CA2796496A1 (en) 2011-10-20
AU2011239489A1 (en) 2012-11-08
EP2558966B1 (en) 2014-07-16
EP2558967B1 (en) 2020-04-15
EP3706134A1 (en) 2020-09-09
CA2796505A1 (en) 2011-10-20
AU2011239489B2 (en) 2015-04-02
JP2015221383A (ja) 2015-12-10
MX347513B (es) 2017-04-28
WO2011130669A1 (en) 2011-10-20
CO6660434A2 (es) 2013-04-30
JP2022095842A (ja) 2022-06-28
JP5747072B2 (ja) 2015-07-08
EP2558967A1 (en) 2013-02-20
MX2012012061A (es) 2013-06-28
JP2017094150A (ja) 2017-06-01
JP2019188179A (ja) 2019-10-31
CO6630153A2 (es) 2013-03-01
MX2012012062A (es) 2013-06-28
MX389975B (es) 2025-03-20
JP6543279B2 (ja) 2019-07-10
MX2022001536A (es) 2022-05-26
NZ602996A (en) 2015-02-27
WO2011130668A1 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
US20220218886A1 (en) Therapy prediction and optimization for renal failure blood therapy
AU2011239489B2 (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
US9132219B2 (en) Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
EP3229159B1 (en) Optimization of serum potassium for renal failure blood therapy, especially home hemodialysis
AU2015203634B2 (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140916

MKLA Lapsed

Effective date: 20220419